Obesity+1
RecruitingStudy on the Effectiveness and Safety of Orforglipron for Weight Management in Adolescents with Obesity or Overweight
- Disease:ObesityOverweight
- Substances:–
Poland- Participants:0–17 years
- Sponsor:Eli Lilly & Co.
Rare diseases
Investigational molecules
Locations
Ul. Raclawicka 129/2u, 02-117 Warsaw, Poland
Instytut Diabetologii Sp. z o.o. in Warsaw, Poland specialises in clinical trials of conditions such as Obesity, Type 2 diabetes mellitus, Overweight, Diabetes mellitus, and other specialisations. This site conducts important research.
At Instytut Diabetologii Sp. z o.o. in Warsaw, clinical trials are focused on cardiovascular diseases and nutritional and metabolic diseases, with a strong emphasis on metabolism. The studies mainly examine type 2 diabetes mellitus, obesity, and related high-risk conditions, aiming to improve long-term disease control and support better health outcomes.
Several projects are designed to test whether emerging therapies can better reduce body weight, improve blood sugar management, and lower the risk of major heart-related events in people with metabolic disease.
A major part of the research at this site centers on type 1 diabetes mellitus, especially in people newly diagnosed or in the early stages of the disease. These studies investigate whether treatment can help preserve insulin-producing cells, maintain beta cell function, and support better glucose regulation over time.
The work includes follow-up and treatment studies that look at safety, tolerability, and the potential to slow the natural decline in pancreatic function.
The site also conducts multiple trials in obesity and overweight, including studies in adolescents and adults. These trials are designed to evaluate new therapies that may help people achieve meaningful weight reduction and improve related metabolic health concerns.
These studies are aimed at finding safer and more effective ways to support weight management, with attention to both standalone obesity care and obesity linked to diabetes.
Clinical trials currently enrolling participants at this site.
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
PolandGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.